Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 235
Filtrar
1.
Reprod Fertil Dev ; 362024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38870343

RESUMEN

Context Carbon tetrachloride (CCl4 ) is a chemical that is still widely used in industry and has been shown to cause structural defects in rat testicles through oxidative stress. Aims In our study, the effect of curcumin on CCl4 -mediated testicular damage was investigated. Methods Twenty-four adult Wistar albino male rats weighing 300-350g were divided into four groups: control group (olive oil was applied by gavage every consecutive day for 3weeks); curcumin and CCl4 +curcumin groups (200mg/kg curcumin dissolved in olive oil was given by gavage once a day, every consecutive day for 3weeks); and CCl4 and CCl4 +curcumin groups (0.5mL/kg CCl4 was dissolved in olive oil at a ratio of 1/1 and given by i.p. injection every other day for 3weeks). Tissue samples were examined histopathologically, histomorphometrically, immunohistochemically and biochemically. Key results CCl4 disrupted both testicular morphology and testosterone synthesis, whereas curcumin treatment resulted in an improvement in testicular morphology and biochemical parameters, as well as a decrease in caspase-3 and tumour necrosis factor-α expression. Conclusions Curcumin has a protective effect on testicular tissue damage caused by CCl4 with its anti-inflammatory, antiapoptotic and antioxantioxidant properties. Implications Curcumin can prevent testicular damage due to CCl4 , an environmental pollutant.


Asunto(s)
Tetracloruro de Carbono , Curcumina , Estrés Oxidativo , Ratas Wistar , Testículo , Testosterona , Animales , Masculino , Curcumina/farmacología , Testículo/efectos de los fármacos , Testículo/patología , Testículo/metabolismo , Testosterona/sangre , Ratas , Estrés Oxidativo/efectos de los fármacos , Factor de Necrosis Tumoral alfa/metabolismo , Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Enfermedades Testiculares/prevención & control , Enfermedades Testiculares/patología , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/metabolismo
2.
Reprod Sci ; 31(8): 2433-2446, 2024 08.
Artículo en Inglés | MEDLINE | ID: mdl-38658488

RESUMEN

One of the adverse effects of the antineoplastic drug cisplatin (CS) is damage to testicular tissue. This study aimed to examine the potential therapeutic effect of thymoquinone (TQ), a strong antioxidant, against testicular damage caused by CS. In the experiment, 28 rats were used, and the rats were randomly divided into four groups: control (n = 7), CS (n = 7), CS + TQ (n = 7), and TQ (n = 7). The experiment was called off after all treatments were finished on day 15. Blood serum and testicular tissues were utilized for biochemical, histological, immunohistochemical, mRNA expression, and gene protein investigations. The testosterone level decreased and oxidative stress, histopathological damage, dysregulation in mitochondrial dynamics, inflammation and apoptotic cells increased in testicular tissue due to CS administration. TQ supplementation showed anti-inflammatory, antioxidant, and anti-apoptotic effects in response to CS-induced testicular damage. In addition, TQ contributed to the reduction of CS-induced toxic effects by regulating the TNF-α/OTULIN/NF-κB pathway. TQ supplementation may be a potential therapeutic strategy against CS-induced testicular damage by regulating the TNF-α/OTULIN/NF-κB axis, inhibiting inflammation, oxidative stress, and apoptosis.


Asunto(s)
Antineoplásicos , Benzoquinonas , Cisplatino , FN-kappa B , Estrés Oxidativo , Testículo , Factor de Necrosis Tumoral alfa , Masculino , Animales , Benzoquinonas/farmacología , Cisplatino/toxicidad , FN-kappa B/metabolismo , Testículo/efectos de los fármacos , Testículo/metabolismo , Testículo/patología , Factor de Necrosis Tumoral alfa/metabolismo , Ratas , Estrés Oxidativo/efectos de los fármacos , Antineoplásicos/farmacología , Transducción de Señal/efectos de los fármacos , Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Ratas Sprague-Dawley , Testosterona/sangre , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/patología , Enfermedades Testiculares/metabolismo , Enfermedades Testiculares/tratamiento farmacológico
3.
Biofactors ; 50(4): 845-862, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38344831

RESUMEN

The prevalence of testicular dysfunction is increasing as it is a common diabetes mellites (DM) complication. The objective of this study is to explore the potential protective effect of sulbutiamine against testicular hypofunction associated with streptozotocin (STZ)-induced DM in rats. Sulbutiamine was administered orally (60 mg/kg) to male Wistar rats for 8 weeks starting 72 h after a single injection of STZ (45 mg/kg, i.p.). Blood glucose level (BGL), serum testosterone level, sperm number, and motility were determined. Testicular tissue was examined histopathologically, and the Johnson score was evaluated. Levels of malondialdehyde (MDA), protein kinase C (PKC), nuclear factor erythroid-derived 2-like 2 (Nrf2), and proliferating cell nuclear antigen (PCNA) were measured. Apoptosis was evaluated by immunohistochemical determination of B-cell lymphoma protein 2 (Bcl-2), Bcl-2 associated X-protein (Bax), and caspase-3. Sulbutiamine administration managed to reduce BGL and boost testicular function as manifested by increased testicular weight, testosterone level, sperm number, and motility compared to the STZ group. Additionally, histopathological examination revealed an improved histological picture and Johnson score of testicular tissue after sulbutiamine treatment. Sulbutiamine administration reduced testicular PKC, MDA, and PCNA levels and increased Nrf2 compared to the untreated group. Moreover, sulbutiamine treatment suppressed apoptosis triggered by STZ as evidenced by elevated Bcl-2, decreased Bax and reduced caspase-3. The present work revealed for the first time a promising protective role of sulbutiamine against STZ-induced testicular dysfunction which may add to the clinical utility of sulbutiamine. The underlying mechanisms involve reducing BGL and PKC, activating Nrf2 and inhibiting apoptosis.


Asunto(s)
Apoptosis , Diabetes Mellitus Experimental , Factor 2 Relacionado con NF-E2 , Proteína Quinasa C , Proteínas Proto-Oncogénicas c-bcl-2 , Ratas Wistar , Transducción de Señal , Testículo , Masculino , Animales , Ratas , Factor 2 Relacionado con NF-E2/metabolismo , Testículo/efectos de los fármacos , Testículo/metabolismo , Testículo/patología , Transducción de Señal/efectos de los fármacos , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/complicaciones , Diabetes Mellitus Experimental/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteína Quinasa C/metabolismo , Apoptosis/efectos de los fármacos , Testosterona/sangre , Malondialdehído/metabolismo , Antígeno Nuclear de Célula en Proliferación/metabolismo , Estrés Oxidativo/efectos de los fármacos , Glucemia/metabolismo , Glucemia/efectos de los fármacos , Estreptozocina , Enfermedades Testiculares/prevención & control , Enfermedades Testiculares/metabolismo , Enfermedades Testiculares/etiología , Enfermedades Testiculares/tratamiento farmacológico , Enfermedades Testiculares/patología , Enfermedades Testiculares/inducido químicamente
4.
Food Chem Toxicol ; 182: 114181, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37972751

RESUMEN

Cadmium is a common environmental pollutant in daily life, the toxic mechanisms of chronic cadmium exposure on the testes have not been fully elucidated. This study aimed to explore the effects of cadmium exposure on male reproductive health and its mechanism. The results showed that cadmium exposure led widened interstitial spaces, abnormal seminiferous tubule morphology, and decreased Leydig cell numbers. Moreover, sperm quality was significantly reduced, along with a decrease in fertility rate. And cadmium exposure could activate the hypothalamic-pituitary-adrenal (HPA) axis, elevate blood glucocorticoid levels, subsequently increase glucocorticoid receptor (GR) expression and activation in testicular Leydig cells. Then GR act on the glucocorticoid receptor element (GRE) in the DNA methyltransferase 3 A (DNMT3A) promoter region and upregulate DNMT3A expression. Consequently, this led to an increase in DNA methylation levels in the angiotensin II receptor 2 (AT2R) promoter region, resulting in reduced AT2R expression and inhibiting testicular steroidogenesis. This study systematically elucidated that cadmium exposure could lead to testicular steroidogenesis suppression and decreased fertility through the GR/DNMT3A/AT2R signaling pathway. This research further provides theoretical and experimental evidence for confirming the threat of cadmium exposure to human reproduction, and contributes to the guidance and protection of male reproductive health.


Asunto(s)
Cadmio , Enfermedades Testiculares , Ratas , Masculino , Humanos , Animales , Cadmio/toxicidad , Cadmio/metabolismo , Receptores de Glucocorticoides/metabolismo , Semen/metabolismo , Testículo , Células Intersticiales del Testículo/metabolismo , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/metabolismo
5.
Int J Mol Sci ; 24(20)2023 Oct 23.
Artículo en Inglés | MEDLINE | ID: mdl-37895159

RESUMEN

Diabetes mellitus is a metabolic disorder associated with various complications encompassing male reproductive dysfunction. The present study aimed to investigate the therapeutic potential of biologically active Lepidium sativum seed oil (LSO) against the testicular dysfunction associated with streptozotocin (STZ)-induced diabetes. Male adults (n = 24) were divided into four groups: control, LSO-administered, diabetic (D), and LSO-treated diabetic (D+LSO) groups. LSO was extracted from L. sativum seeds, and its chemical composition was determined using GC-MS. Serum testosterone levels, testicular enzymatic antioxidants (catalase (CAT) and superoxide dismutase (SOD)), an oxidative stress (OS) biomarker, malondialdehyde (MDA), pro-inflammatory markers (NF-kB, IL-1, IL-6, and TNF-α), and the expression level of NF-kB were assessed. In addition, histopathological changes were evaluated in testicular tissues. The results obtained showed that the chemical composition of LSO indicated its enrichment mainly with γ-tocopherol (62.1%), followed by 2-methylhexacosane (8.12%), butylated hydroxytoluene (8.04%), 10-Methylnonadecane (4.81%), and δ-tocopherol (3.91%). Moreover, LSO administration in the D+LSO mice significantly increased testosterone levels and ameliorated the observed testicular oxidative damage, inflammatory response, and reduced NF-kB expression compared to the diabetic mice. Biochemical and molecular analyses confirmed the histological results. In conclusion, LSO may prevent the progression of diabetes-induced impairment in the testes through inhibition of the OS- and NF-kB-mediated inflammatory response.


Asunto(s)
Diabetes Mellitus Experimental , Enfermedades Testiculares , Humanos , Ratones , Masculino , Animales , Testículo/metabolismo , Lepidium sativum/metabolismo , FN-kappa B/metabolismo , Diabetes Mellitus Experimental/metabolismo , Estrés Oxidativo , Antioxidantes/metabolismo , Enfermedades Testiculares/metabolismo , Inflamación/metabolismo , Testosterona/metabolismo , Aceites de Plantas/farmacología , Aceites de Plantas/uso terapéutico , Aceites de Plantas/metabolismo
6.
J Ethnopharmacol ; 313: 116528, 2023 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-37127141

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Artemisia annua L., known as "sweet wormwood," is widely used in Egyptian folk medicine. Egyptians implement the aerial parts in the treatment of respiratory, digestive and sexual dysfunctions. However, the mechanism by which Artemisia annua improves testicular function is still being discovered. AIM OF THE STUDY: This study aimed to evaluate the modulatory effects of the crude leaf extract of Artemisia annua (AAE) on a high-fat diet induced testicular dysfunction in rats and compare it with the antilipolytic drug Orlistat. MATERIAL AND METHODS: Forty adult rats were randomly classified and assigned to four groups. The first group typically consumed a balanced diet and served as a negative control (GP1). A high-fat diet-induced obesity was applied to the other three groups for 12 weeks. A positive control remained on HFD for another 8 weeks, which is GP2. Other groups were administered for 8 consecutive weeks either with Orlistat (50 mg/kg body weight) or AAE (100 mg/kg body weight), which have been defined as GP3 and GP4, respectively. Testosterone (TST), follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were determined in the sera of all groups. In addition, the oxidant/antioxidant biomarkers such as protein carbonyl, malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT) activities, lactate dehydrogenase (LDH) and creatine kinase isoenzyme-B (CK-MB) were determined. An immunohistochemical stain with the apoptotic marker caspase-3 and the proliferating cell nuclear antigen (PCNA) were also investigated. RESULTS: In the testes of the obese group, the results showed hormonal imbalance, an increase in oxidative stress biomarkers and apoptosis. In the group treated with orlistat (GP3), noticeably more perturbations were noted. The obese rats that had been treated with AAE (GP4) showed a significantly reduced level of oxidative stress, hormonal balance restoration and reduced apoptosis. CONCLUSIONS: The crude leaf extract of A. annua is a potential herbal therapeutic for the treatment of obesity-related testicular dysfunction and the restoration of hormonal imbalance in obese rats.


Asunto(s)
Artemisia annua , Enfermedades Testiculares , Masculino , Humanos , Ratas , Animales , Dieta Alta en Grasa/efectos adversos , Orlistat/metabolismo , Orlistat/farmacología , Orlistat/uso terapéutico , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Extractos Vegetales/metabolismo , Obesidad/tratamiento farmacológico , Obesidad/metabolismo , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Antioxidantes/metabolismo , Espermatogénesis , Estrés Oxidativo , Testículo/metabolismo , Enfermedades Testiculares/metabolismo , Biomarcadores/metabolismo
7.
Biomed Pharmacother ; 164: 114903, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37224756

RESUMEN

BACKGROUND: Male infertility is a worldwide problem but few treatments, especially irradiation-induced testicular injury. The aim of this research was to investigate novel drugs for the treatment of irradiation-induced testicular injury. METHODS: We administered dibucaine (0.8 mg/kg) intraperitoneally to male mice (6 mice per group) after five consecutive daily 0.5 Gy whole-body irradiation, and evaluated its ameliorating efficacy by testicular HE staining and morphological measurements. Drug affinity responsive target stability assay (Darts) were used to find target protein and pathway; mouse primary Leydig cells were isolated and to explore the mechanism (Flow cytometry, Western blot, and Seahorse palmitate oxidative stress assays); finally rescue experiments were completed by combining dibucaine with fatty acid oxidative pathway inhibitors and activators. RESULTS: The testicular HE staining and morphological measurements in dibucaine treatment group was significantly better than that in irradiation group (P < 0.05); sperm motility and mRNA levels of spermatogenic cell markers were also higher than those in the latter (P < 0.05). Darts and Western blot results showed that dibucaine targets CPT1A and downregulate fatty acid oxidation. Flow cytometry, Western blot, and Palmitate oxidative stress assays of primary Leydig cells demonstrated that dibucaine inhibits fatty acid oxidation in Leydig cells. Dibucaine combined with etomoxir/baicalin confirmed that its inhibition of fatty acid oxidation was beneficial in ameliorating irradiation-induced testicular injury. CONCLUSIONS: In conclusion, our data suggest that dibucaine ameliorates irradiation-induced testicular injury in mice by inhibiting fatty acid oxidation in Leydig cells. This will provide novel ideas for the treatment of irradiation-induced testicular injury.


Asunto(s)
Células Intersticiales del Testículo , Enfermedades Testiculares , Humanos , Masculino , Ratones , Animales , Células Intersticiales del Testículo/metabolismo , Dibucaína/metabolismo , Motilidad Espermática , Testículo/metabolismo , Enfermedades Testiculares/metabolismo , Ácidos Grasos/metabolismo , Palmitatos
8.
Toxicol Appl Pharmacol ; 456: 116262, 2022 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-36198370

RESUMEN

Testicular dysgenesis syndrome in male neonates manifests as cryptorchidism and hypospadias, which can be mimicked by in utero phthalate exposure. However, the underlying phthalate mediated mechanism and therapeutic effects of taxifolin remain unclear. Di-(2-ethylhexyl) phthalate (DEHP) is the most abundantly used phthalate and can induce testicular dysgenesis syndrome in male rats. To explore the mechanism of DEHP mediated effects and develop a therapeutic drug, the natural phytomedicine taxifolin was used. Pregnant Sprague-Dawley female rats were daily gavaged with 750 mg/kg/d DEHP or 10 or 20 mg/kg/d taxifolin alone or in combination from gestational day 14 to 21, and male pup's fetal Leydig cell function, testicular MDA, and antioxidants were examined. DEHP significantly reduced serum testosterone levels of male pups, down-regulated the expression of SCARB1, CYP11A1, HSD3B1, HSD17B3, and INSL3, reduced the cell size of fetal Leydig cells, decreased the levels of antioxidant and related signals (SOD2 and CAT, SIRT1, and PGC1α), induced abnormal aggregation of fetal Leydig cells, and stimulated formation of multinucleated gonocytes and MDA levels. Taxifolin alone (10 and 20 mg/kg/d) did not affect these parameters. However, taxifolin significantly rescued DEHP-induced alterations. DEHP exposure in utero can induce testicular dysgenesis syndrome by altering the oxidative balance and SIRT1/PGC1α levels, and taxifolin is an ideal phytomedicine to prevent phthalate induced testicular dysgenesis syndrome.


Asunto(s)
Dietilhexil Ftalato , Enfermedades Testiculares , Embarazo , Humanos , Ratas , Masculino , Femenino , Animales , Dietilhexil Ftalato/toxicidad , Animales Recién Nacidos , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma/metabolismo , Testosterona/metabolismo , Sirtuina 1/metabolismo , Ratas Sprague-Dawley , Células Intersticiales del Testículo , Testículo , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/prevención & control , Enfermedades Testiculares/metabolismo , Estrés Oxidativo , Antioxidantes/farmacología , Antioxidantes/metabolismo
9.
Andrologia ; 54(10): e14544, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-35899326

RESUMEN

The current study investigated the possible protective effects of Coenzyme Q10 (Co Q10 ) on rat model of high-fat diet (HFD) induced testicular dysfunction. Thirty male Wistar rats were allocated randomly into three groups: control, HFD, HFD + Co Q10 (75 mg/kg/day) groups. Animals were sacrificed after 3 months and epididymal sperm suspension, blood, and testes were collected for further analysis. In comparison to the untreated HFD group, the Co Q10 treated group revealed significantly increased serum testosterone, adiponectin levels, and decreased LH, FSH, and leptin levels. In addition, HFD resulted in significant increase in testicular oxidative stress (increased MDA, iNOS, NO, XO & decreased catalase, SOD, GSH) and inflammation (increased pJNK/JNK, pERK/ERK, and p-p38MAPK/MAPK), while Co Q10 was effective to ameliorate these changes. In addition, Co Q10 significantly increased sperm count, motility and viability that were markedly deteriorated by HFD. Regarding testicular ultrastructure, seminiferous tubular diameter and epithelium height were reduced in HFD group and Co Q10 significantly improved these testicular changes. Finally, a significant reduction in spermatogenic cell proliferation was detected by PCNA fluorescent expression and Co Q10 significantly reversed this change. In summary, our results indicated that Co Q10 could suppress testicular dysfunction produced by HFD. This protective effect could be attributed to its antioxidant, anti-inflammatory properties and to its effect on adipokines and spermatogenic cell proliferation. So, Co Q10 may be a promising food supplement to protect against testicular dysfunction induced by HFD.


Asunto(s)
Enfermedades Testiculares , Testículo , Adipoquinas/metabolismo , Adipoquinas/farmacología , Adiponectina , Animales , Antiinflamatorios/farmacología , Antioxidantes/metabolismo , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Catalasa/metabolismo , Dieta Alta en Grasa/efectos adversos , Hormona Folículo Estimulante/metabolismo , Humanos , Leptina/farmacología , Sistema de Señalización de MAP Quinasas , Masculino , Estrés Oxidativo , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas , Ratas Wistar , Semen/metabolismo , Superóxido Dismutasa/metabolismo , Enfermedades Testiculares/metabolismo , Testosterona/metabolismo , Ubiquinona/farmacología , Ubiquinona/uso terapéutico
10.
Aging Cell ; 21(8): e13656, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-35770332

RESUMEN

Hypothalamic integrity increasingly is being recognized as a marker of healthy longevity in rodent models. Insight into hypothalamic function in humans with exceptional longevity can be gained via investigation of the hypothalamic-pituitary-testicular (HPT) axis in men with exceptional longevity. This study aimed to characterize the HPT axis function, defined by levels of testosterone (T) and luteinizing hormone (LH), in 84 Ashkenazi Jewish men aged 90-106 years. We found that 94% of men exhibited preserved hypothalamic-pituitary function, as evidenced by either normal testosterone and LH levels (25%) or an appropriate rise in LH in response to aging-related primary testicular dysfunction (69%), a hormone pattern mirroring female menopause. Total T level was not associated with metabolic parameters or survival. These results demonstrate a high prevalence of testicular dysfunction with preserved hypothalamic-pituitary function in men with exceptional longevity. Thus, the role of hypothalamic integrity and HPT axis in healthy aging warrants further investigation.


Asunto(s)
Hipotálamo , Longevidad , Hipófisis , Testículo , Envejecimiento/sangre , Envejecimiento/metabolismo , Hormona Folículo Estimulante/metabolismo , Humanos , Hipotálamo/metabolismo , Longevidad/fisiología , Hormona Luteinizante/sangre , Hormona Luteinizante/metabolismo , Masculino , Hipófisis/metabolismo , Enfermedades Testiculares/sangre , Enfermedades Testiculares/metabolismo , Testículo/metabolismo , Testosterona/sangre , Testosterona/metabolismo
11.
Comput Math Methods Med ; 2022: 7174399, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35242210

RESUMEN

The testicles and sperm are extremely susceptible to inflammation and oxidative stress. Although Zhibai Dihuang Pill (ZDP) has been reported to treat various infertilities including male infertility induced by Ureaplasma urealyticum (UU) infection, its mechanism is still poorly understood. This study is aimed at clarifying the underlying mechanism of ZDP to protect against UU-infected male infertility. We found that UU-infected infertile rats exhibited weight loss, reduced food intake, and decreased sperm count and vitality. The administration of ZDP improved the general state and sperm motility of rats. In addition, UU infection led to spermatogenesis disorders, impaired secretory function and blood-testis barrier (BTB) of Sertoli cells, and elevated inflammation and oxidative stress. As expected, ZDP suppressed inflammation and oxidative stress to alleviate spermatogenesis disorders. Our research showed that ZDP could improve spermatogenesis disorders and testicular function primarily through the mitogen-activated protein kinase (MAPK) signaling pathway. ZDP exerts its anti-inflammatory and antioxidant effects via the MAPK signaling pathway, thus playing an important role in ameliorating spermatogenesis failure and testicular dysfunction.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Infertilidad Masculina/tratamiento farmacológico , Enfermedades Testiculares/tratamiento farmacológico , Infecciones por Ureaplasma/tratamiento farmacológico , Ureaplasma urealyticum , Animales , Biología Computacional , Modelos Animales de Enfermedad , Humanos , Infertilidad Masculina/etiología , Infertilidad Masculina/metabolismo , Mediadores de Inflamación/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Masculino , Estrés Oxidativo/efectos de los fármacos , Fitoterapia , Ratas , Ratas Sprague-Dawley , Espermatogénesis/efectos de los fármacos , Enfermedades Testiculares/etiología , Enfermedades Testiculares/metabolismo , Testículo/efectos de los fármacos , Testículo/metabolismo , Testículo/patología , Infecciones por Ureaplasma/complicaciones , Infecciones por Ureaplasma/metabolismo
12.
Life Sci ; 289: 120218, 2022 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-34890588

RESUMEN

BACKGROUND: Cancer and its therapies can impact fertility in various ways, and therefore a growing number of cancer survivors face fertility as a significant concern. The cytotoxic alkylating agent cyclophosphamide (CP) is commonly used as an antineoplastic agent; unfortunately, its use is significantly associated with male infertility and damage to the reproductive system. AIM: The present study aimed to assess the possible beneficial effects of Irbesartan (IRB) in a rat model of CP-induced testicular toxicity. MAIN METHODS: The effects of treatment were assessed by measuring peroxisome proliferator-activated receptor gamma (PPAR-γ) expression via qRT-PCR, the immunohistochemical (IHC) assessment of apoptotic markers, NOD-like receptor protein 3 (NLRP3), and nuclear factor-κB (NF-κB), determination of the count and viability of epididymal sperm, oxidative stress markers via biochemical analysis, serum testosterone, caspase-1, and interleukin-18 (IL-18) levels via ELISA, histopathological assessment, and fibrosis by Masson's trichrome (MT) stain. KEY FINDINGS: There was a significant increase in malondialdehyde (MDA), caspase-1, and IL-18 contents, NF-κB, NLRP3, Bcl-2-associated X protein (Bax), caspase-3, and MT staining in testicular tissue after CP administration compared to the normal control group. Whereas reduced glutathione (GSH), superoxide dismutase (SOD), PPAR-γ expression, B-cell lymphoma-2 (Bcl-2) staining, serum testosterone, and the count and viability of epididymal sperm were decreased compared to the normal control group. The IRB treatment has reversed CP-induced testicular toxicity. SIGNIFICANCE: It is possible to conclude that IRB revealed a significant testicular protective effect against CP via antioxidant, anti-apoptotic, and anti-inflammatory effects.


Asunto(s)
Ciclofosfamida/efectos adversos , Interleucina-18/biosíntesis , Irbesartán/farmacología , FN-kappa B/biosíntesis , Proteína con Dominio Pirina 3 de la Familia NLR/biosíntesis , PPAR gamma/biosíntesis , Transducción de Señal/efectos de los fármacos , Enfermedades Testiculares , Regulación hacia Arriba/efectos de los fármacos , Animales , Ciclofosfamida/farmacología , Infertilidad Masculina/inducido químicamente , Infertilidad Masculina/tratamiento farmacológico , Infertilidad Masculina/metabolismo , Infertilidad Masculina/patología , Masculino , Ratas , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/tratamiento farmacológico , Enfermedades Testiculares/metabolismo , Enfermedades Testiculares/patología
13.
Toxicol Appl Pharmacol ; 433: 115772, 2021 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-34715073

RESUMEN

The cancer therapy using cyclophosphamide (CP) has been associated with adverse effects on the testicular function that raises concerns about the future fertility potential among cancer survivors. Curcumin, a polyphenol, has shown to possess a plethora of biological functions including tissue protective effects. In the present study, we investigated the protective effects of curcumin nanocrystals (NC) in mitigation of CP-induced testicular toxicity. Healthy adult (8-10 week) and prepubertal (2 week) male Swiss albino mice were injected with a single dose of CP (200 mg/kg) intraperitoneally (i.p). NC (4 mg/kg, i.p.) was administered every alternate day, for 35 days in adult mice while, a single dose of NC was injected intraperitoneally to prepubertal mice 1 h prior to CP. Administration of multiple doses of NC ameliorated CP-induced testicular toxicity in adult mice, which was evident from the improved sperm functional competence, sperm chromatin condensation, seminiferous tubule architecture and decreased apoptosis in testicular cells. Further, administration of NC 1 h prior to CP in prepubertal mice modulated the expression of genes pertaining to proliferation, pluripotency, DNA damage and DNA repair in spermatogonial cells at 24 h after the treatment. Overall, these results suggest that NC could be a promising chemoprotective agent, which can have potential application in male fertility preservation.


Asunto(s)
Antineoplásicos Alquilantes/toxicidad , Antioxidantes/farmacología , Curcumina/farmacología , Ciclofosfamida/toxicidad , Nanopartículas , Espermatogonias/efectos de los fármacos , Enfermedades Testiculares/prevención & control , Testículo/efectos de los fármacos , Animales , Antioxidantes/química , Proliferación Celular/efectos de los fármacos , Curcumina/química , Daño del ADN/efectos de los fármacos , Composición de Medicamentos , Regulación de la Expresión Génica , Infertilidad Masculina/inducido químicamente , Infertilidad Masculina/metabolismo , Infertilidad Masculina/patología , Infertilidad Masculina/prevención & control , Masculino , Ratones , Estrés Oxidativo/efectos de los fármacos , Espermatogonias/metabolismo , Espermatogonias/patología , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/metabolismo , Enfermedades Testiculares/patología , Testículo/metabolismo , Testículo/patología , Factores de Tiempo
14.
Biomed Pharmacother ; 143: 112201, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34560547

RESUMEN

Methotrexate (MTX) is commonly used as a therapeutic agent in the treatment of malignancies and autoimmune disorders. Risk of subsequent infertility following MTX administration has been reported as a significant side effect due to testicular toxicity. The aim of the study was to evaluate the modulatory effects of Ginkgo biloba (standardized extract, EGb 761) on MTX-induced testicular oxidative stress, energy deficits and spermatogenic status in rats. All groups received intraperitoneal injection of MTX (0.5 mg/kg) twice weekly for four weeks except the control group that received the corresponding vehicles. Other groups received oral EGb761, at doses 25, 50 or 100 mg/kg/day, for four weeks, concurrently with MTX. Blood and semen sampling followed by testis dissection were performed 24 h after last EGb 761 treatment. Semen was examined for sperm progressive motility, percent of normal spermatozoa and sperm cell concentration as well as seminal plasma essential and non-essential amino acids. Serum LH, FSH and testosterone were detected as well as testicular MDA, GSH, GSSG, TNF-α, IL-1ß, IL-6, NF-κB and the nuclear, cytoplasmic and mRNA expression levels of Nrf-2 besides the testicular cell energy; AMP, ADP and ATP. Histopathological studies of interstitial fibrosis and the severity of germ cell degeneration were also conducted. MTX induced significant decline in sperm quality along with decreased essential and non-essential amino acids in seminal plasma. MTX reduced serum FSH, LH and testosterone as well as testicular ATP, GSH and Nrf2, while increased levels of testicular ADP, AMP, MDA, GSSG and TNF-α. Results were confirmed by prominent interstitial fibrosis and severe germ cell degeneration in MTX group. Concurrent treatment with EGb 761 alleviated MTX-induced testicular insult evidenced by amelioration of oxidative stress biomarkers, energy functions, seminal sperms abnormalities and spermatogenesis status. The present study suggests a beneficial role of EGb 761 in MTX-induced testicular injury and subsequent distortion of spermatogenesis.


Asunto(s)
Antioxidantes/farmacología , Metabolismo Energético/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Espermatogénesis/efectos de los fármacos , Espermatozoides/efectos de los fármacos , Enfermedades Testiculares/prevención & control , Testículo/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Fibrosis , Ginkgo biloba , Masculino , Metotrexato , Factor 2 Relacionado con NF-E2/genética , Factor 2 Relacionado con NF-E2/metabolismo , Ratas Wistar , Espermatozoides/metabolismo , Espermatozoides/patología , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/metabolismo , Enfermedades Testiculares/patología , Testículo/metabolismo , Testículo/patología
15.
Food Chem Toxicol ; 155: 112409, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34265366

RESUMEN

Although circular RNAs (circRNAs) can function as microRNAs (miRNAs) sponges to participate in spermatogenesis, little is known about the functions of circRNAs in testis exposed to formaldehyde. In this study, twenty-four male SD rats (6-8 weeks) were randomly assigned to four groups, including a control group, 0.5, 2.46, and 5 mg/m3 formaldehyde exposure groups, inhaling formaldehyde for eight consecutive weeks. The RT-qPCR was used to detect the expression of rno_circRNA_016194; the testicular injuries were observed by testicular histopathology. Our study illustrated up-regulated rno_circRNA_016194 was dose-dependent with formaldehyde. Simultaneously, the testicular histopathology showed an obvious damages in the 2.46 and 5 mg/m3 formaldehyde exposure rats. Combined with bioinformatics analysis, the rno-miR-449a-5p was predicted and verified that its expression decreased in the testis exposed to formaldehyde. Meanwhile, the testicular morphometry changes were contrary to the expression of rno_circRNA_016194 and consistent with rno-miR-449a-5p. Moreover, bioinformatics analysis also prompted the potential downstream target gene for rno_circRNA_016194/rno-miR-449a-5p was Atg4b, and Atg4b expression was up-regulated in rats exposed to formaldehyde verifying by Western blot. Collectively, the rno_circRNA_016194 might be involved in formaldehyde-induced male reproductive toxicity and become potential therapeutic targets for male occupational exposure to formaldehyde.


Asunto(s)
Proteínas Relacionadas con la Autofagia/metabolismo , Cisteína Endopeptidasas/metabolismo , MicroARNs/metabolismo , ARN Circular/metabolismo , Enfermedades Testiculares/metabolismo , Animales , Formaldehído , Masculino , Ratas Sprague-Dawley , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/patología , Testículo/efectos de los fármacos , Testículo/metabolismo , Testículo/patología
16.
Biomed Res Int ; 2021: 4615384, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33604374

RESUMEN

Proton pumps are membrane-bound enzymes important in generating gradients that help in maintaining cellular ion homeostasis, cell membrane potential, water, and solute transport across the cell surface. This study investigated the modulatory role of vitamin E on proton pump activity and reproductive parameters in cadmium-induced testicular damage. Twenty (20) male Wistar rats weighing between 180 and 200 g were sorted into 4 groups of five rats each. Group I served as the control and was given normal saline orally, Group II rats were treated with a single dose of 2 mg/kg BW cadmium chloride (CdCl2) intraperitoneally, Group III rats were given 100 mg/kg BW of vitamin E orally, and Group IV rats were given 100 mg/kg BW of vitamin E orally for 30 days prior to intraperitoneal administration of single dose of 2 mg/kg BW of cadmium chloride. The rats were anaesthetized with diethyl ether, and blood samples were obtained for sex hormonal analysis; caudal epididymis was dissected for sperm count, motility, and viability, and the testis were homogenized for lipid peroxidation and proton pump (Na+/K+ ATPase, Ca2+ ATPase, and Mg2+ ATPase) activity. Proton pump activity was assayed spectrophotometrically using the Stewart method to determine the inorganic phosphate level. Histopathological changes of the testis were also studied. The group treated with CdCl2 showed a significant (p < 0.05) decrease in proton pump activity, sperm count, and motility and a significant (p < 0.05) increase in malondialdehyde level when compared with the control group. The CdCl2-treated group also showed decrease reproductive organ weights and hormonal levels and cause necrosis of spermatogonia lining the seminiferous tubules. Rats treated with vitamin E orally for 30 days prior to CdCl2 exposure showed improvement in proton pump activity, a significant (p < 0.05) increase in sperm parameters and luteinizing hormonal level, and a decrease in the lipid peroxidation level as compared with the CdCl2 group. This study showed that vitamin E ameliorated the toxic effect of CdCl2 on proton pump activity in the testes, hence improving testicular integrity, structures, and functions.


Asunto(s)
Adenosina Trifosfatasas , Cloruro de Cadmio/efectos adversos , Bombas de Protones , Testículo , Vitamina E/farmacología , Adenosina Trifosfatasas/efectos de los fármacos , Adenosina Trifosfatasas/metabolismo , Animales , Peroxidación de Lípido/efectos de los fármacos , Masculino , Tamaño de los Órganos/efectos de los fármacos , Bombas de Protones/efectos de los fármacos , Bombas de Protones/metabolismo , Ratas , Ratas Wistar , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/metabolismo , Testículo/efectos de los fármacos , Testículo/enzimología , Testículo/metabolismo , Testículo/patología
17.
Life Sci ; 269: 119031, 2021 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-33453244

RESUMEN

AIMS: Cadmium (Cd) is a prevalent environmental contaminant that incurs deleterious health effects, including testicular impairment. Sitagliptin, a selective dipeptidyl peptidase-4 (DPP-4) inhibitor, has demonstrated marked cardio-, hepato-, and reno-protective actions, however, its impact on Cd-triggered testicular dysfunction has not been formerly investigated. Hence, the present study aimed to explore the probable beneficial impact of sitagliptin against Cd-evoked testicular impairment which may add to its potential clinical utility. The underlying mechanisms pertaining to the balance between testicular autophagy and apoptosis were explored, including the AMPK/mTOR and Nrf2/HO-1 pathways. MATERIALS AND METHODS: The testicular tissues were examined using histopathology, immunohistochemistry, Western blotting, and ELISA. Sitagliptin (10 mg/kg/day, by gavage) was administered for 4 consecutive weeks. KEY FINDINGS: Sitagliptin attenuated the testicular impairment via improvement of the relative testicular weight, sperm count/motility, sperm abnormalities, and serum testosterone. Additionally, sitagliptin counteracted Cd-induced histologic aberrations/disrupted spermatogenesis. Interestingly, sitagliptin augmented the defective autophagy as demonstrated by upregulating Beclin 1 protein expression and lowering p62 SQSTM1 protein accumulation. These effects were mediated via the activation of testicular AMPK/mTOR pathway as proven by increasing p-AMPK (Ser485, Ser491)/total AMPK and diminishing p-mTOR (Ser2448)/total mTOR protein expression. Additionally, sitagliptin suppressed the testicular apoptotic events via downregulating Bax and upregulating Bcl-2 protein expression. In tandem, sitagliptin suppressed the oxidative stress through lowering lipid peroxides and activating Nrf2/HO-1 pathway via upregulating the protein expression of Nrf2, and the downstream effectors HO-1 and GPx. SIGNIFICANCE: Sitagliptin attenuated Cd-induced testicular injury via boosting the autophagy/apoptosis ratio through activation of AMPK/mTOR and Nrf2/HO-1 pathways.


Asunto(s)
Autofagia , Cadmio/toxicidad , Regulación de la Expresión Génica/efectos de los fármacos , Fosfato de Sitagliptina/farmacología , Enfermedades Testiculares/tratamiento farmacológico , Testículo/efectos de los fármacos , Proteínas Quinasas Activadas por AMP/genética , Proteínas Quinasas Activadas por AMP/metabolismo , Animales , Hemo Oxigenasa (Desciclizante)/genética , Hemo Oxigenasa (Desciclizante)/metabolismo , Hipoglucemiantes/farmacología , Masculino , Factor 2 Relacionado con NF-E2/genética , Factor 2 Relacionado con NF-E2/metabolismo , Estrés Oxidativo , Ratas , Ratas Sprague-Dawley , Serina-Treonina Quinasas TOR/genética , Serina-Treonina Quinasas TOR/metabolismo , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/metabolismo , Enfermedades Testiculares/patología , Testículo/metabolismo , Testículo/patología
18.
J Inorg Biochem ; 216: 111312, 2021 03.
Artículo en Inglés | MEDLINE | ID: mdl-33388704

RESUMEN

The insulin enhancing activity, histological analysis and, testicular degeneration by a VIVO-complex containing the 2,2'-(ethane-1,2-diylbis(azanediyl))diethanolate ligand, VOIV(C6H14N2O2-κ2N,κ2O), abbreviated VIVO(BHED), were investigated in diabetic male Wistar rats. The complex was administered by oral gavage of freshly prepared solutions of vanadium complex. Biological studies demonstrated that the vanadium complex normalized the elevated glucose levels in male Wistar rats with streptozotocin-induced diabetes and these compounds also avoided common responses in diabetic animals such as weight loss and reduction in the size of the epididymis, prostate, testis and seminal gland. The 51V NMR and EPR studies showed the formation of VIVO(BHED) and the oxidation product [VVO2BHED]- with two possible decomposition pathways. In summary, these studies demonstrate that the VIVO(BHED) complex or its decomposition products show similar effects as insulin in decreasing elevated blood glucose levels.


Asunto(s)
Complejos de Coordinación , Diabetes Mellitus Experimental/tratamiento farmacológico , Diaminas , Hipoglucemiantes , Enfermedades Testiculares/tratamiento farmacológico , Testículo , Vanadio , Animales , Atrofia , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Diaminas/química , Diaminas/farmacología , Hipoglucemiantes/química , Hipoglucemiantes/farmacología , Masculino , Ratas , Ratas Wistar , Enfermedades Testiculares/metabolismo , Enfermedades Testiculares/patología , Testículo/metabolismo , Testículo/patología , Vanadio/química , Vanadio/farmacología
19.
Artículo en Inglés | MEDLINE | ID: mdl-32392119

RESUMEN

BACKGROUND: Cisplatin is a chemotherapeutic drug used to treat testicular cancer that induces testicular toxicity. This study aimed to investigate the possible role of androgens, androgen receptor, and organic cation transporter 2 (OCT2) in the protective effects of curcumin on cisplatininduced testicular toxicity. METHODS: Thirty male Wistar rats were divided into five groups: 1- control (normal saline, 0.5 ml ip, daily for 10 consecutive days); 2- cisplatin (10 mg/kg ip, single dose at the first day); 3- cisplatin + curcumin (10 mg/kg ip, dissolved in 5% DMSO, daily for 10 consecutive days); 4- cisplatin + vehicle (DMSO 5%, 0.3 ml ip); and 5- curcumin (10 mg/kg ip). At the end of the study, a blood sample was obtained for testosterone measurement. The left testis was kept at -80. to measure androgen receptor (AR) and type 2 organic cation transporter (OCT2) gene expression and the right testis were kept in 10% formalin for histological analysis. RESULTS: Cisplatin significantly decreased serum testosterone, declined testis AR gene expression, and increased OCT2 gene expression in testis (p<0.01). Curcumin treatment significantly prevented these alterations in testosterone and gene expressions (p<0.01). Moreover, curcumin significantly reversed the cisplatin-induced kidney tissue injury and increased spermatid and spermatozoa. CONCLUSION: It is concluded that the ameliorative effect of curcumin in cisplatin-induced reproductive disorders was due to the modulation of testosterone and androgen receptors.


Asunto(s)
Curcumina/farmacología , Transportador 2 de Cátion Orgánico/metabolismo , Sustancias Protectoras/farmacología , Receptores Androgénicos/metabolismo , Enfermedades Testiculares/prevención & control , Testículo/efectos de los fármacos , Animales , Cisplatino , Modelos Animales de Enfermedad , Masculino , Transportador 2 de Cátion Orgánico/genética , Ratas Wistar , Receptores Androgénicos/genética , Transducción de Señal , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/metabolismo , Enfermedades Testiculares/patología , Testículo/metabolismo , Testículo/patología , Testosterona/sangre
20.
Toxicol Appl Pharmacol ; 411: 115370, 2021 01 15.
Artículo en Inglés | MEDLINE | ID: mdl-33338516

RESUMEN

BACKGROUND: Inorganic arsenic (iAs) is a worldwide environmental pollutant which exerts complicated and various toxic effects in organisms. Increasingly epidemic studies have revealed the association between iAs exposure and adult male reproductive impairment. Consistent with the proposal for toxicity testing in the 21st century (TT21C), the adverse outcome pathway (AOP) framework may help unravel the iAs-caused molecular and functional changes leading to male reproductive impairment. METHOD: Combining CTD's phenotype-disease inference data, iAs-phenotypes were anchored to five male reproductive diseases induced by iAs, and local network topological algorithm was applied in prioritizing their interference significance. Through integrating analysis in AOP Wiki knowledge base, filtered phenotypes were linked to key events consisting of AOPs and assembled together based on evidentially upstream and downstream relationships. RESULTS: A subset of 655 phenotypes were filtered from CTD as potential key events and showed a significant coherence in five reproductive diseases wherein 39 significant phenotypes showed a good clustering features involving cell cycle, ROS and mitochondria function. Two AOP subnetworks were enriched in AOP Wiki where testosterone reduction and apoptosis of sperm served as focus events respectively. Besides, a candidates list of molecular initialing events was provided of which glucocorticoid receptor activation was overall assessed as an example. CONCLUSION: This study applied computational and bioinformatics methods in generating AOPs for arsenic reproductive toxicity, which identified the imperative roles of testosterone reduction, response to ROS, spermatogenesis and provided a global view about their internal association. Furthermore, this study helped address the existing knowledge gaps for future experimental verification.


Asunto(s)
Arsénico/toxicidad , Genitales Masculinos/efectos de los fármacos , Infertilidad Masculina/inducido químicamente , Reproducción/efectos de los fármacos , Biología de Sistemas , Enfermedades Testiculares/inducido químicamente , Algoritmos , Animales , Apoptosis/efectos de los fármacos , Análisis por Conglomerados , Bases de Datos Genéticas , Fertilidad/efectos de los fármacos , Genitales Masculinos/metabolismo , Genitales Masculinos/fisiopatología , Humanos , Infertilidad Masculina/genética , Infertilidad Masculina/metabolismo , Infertilidad Masculina/fisiopatología , Masculino , Fenotipo , Enfermedades Testiculares/genética , Enfermedades Testiculares/metabolismo , Enfermedades Testiculares/fisiopatología , Testosterona/deficiencia , Toxicogenética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...